Available to sourceHuman Prescription DrugGastrointestinal

PaxLyte

6.4 mg/1 / 800 ug/1 / 500 mg/1 / 1.83 mg/1 / 50 ug/1 / 25 ug/1 / 13.6 mg/1 / 25 ug/1 / 1 mg/1 / 2.5 mg/1 / 7 mg/1 / 24 mg/1 / 1 mg/1 / 25 ug/1 / 12 mg/1 / 25 ug/1 / 1.83 mg/1 / 1 mg/1 · Capsule

By Jaymac Pharmaceuticals

NDC: 64661-217
Route: Oral
Therapeutic class: Acidifying Activity [MoA], Anti-coagulant , Ascorbic Acid [CS], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent , Decreased Coagulation Factor Activity [PE], Folate Analog , Folate Analog , Folic Acid [CS], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylating Activity [MoA], Methylating Agent , Osmotic Activity [MoA], Osmotic Laxative , Vitamin C , Vitamin C
Marketing category: UNAPPROVED DRUG OTHER

Package sizes

30 CAPSULE in 1 BOTTLE (64661-217-30)NDC 64661-217-30Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.